Effects of Alcohol on Simulated Driving
NCT00477984 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2008-04-15
Summary
Previous studies have shown that alcohol significantly impairs driving performance. Acute alcohol administration also has a detrimental effect on secondary task performance during dual-tasks. The present study will investigate the effects of five different dosages of ethanol (0,0.2, 0,5, 0,8 and 1,0 % BAC) on performance in a driving simulator. Steering performance and brain activity will be recorded in both single- and dual-task conditions.
Conditions
- Alcoholism
Interventions
- DRUG
-
alcohol
alcohol(0.02%, 0.05%, 0.08% and 0.10%) and placebo
Sponsors & Collaborators
-
Utrecht Institute for Pharmaceutical Sciences
lead OTHER
Principal Investigators
-
Joris C Verster, PhD · Utrecht Institute for Pharmaceutical Sciences
-
Edmund R Volkerts, PhD · Utrecht Institute for Pharmaceutical Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2008-03-31
- Completion
- 2008-03-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Behavior Brain Responses
NCT03964350 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Driving Simulator Performance After Intake of Zopiclone Sleeping Pills
NCT01257165 ·Status: WITHDRAWN ·Phase: NA
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II
NCT02710097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
NCT02404688 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I
NCT02709954 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Sensory Stimulation During Simulated Driving
NCT03726840 ·Status: COMPLETED ·Phase: NA
-
Dopamine Release in the Human Brain Following Alcohol Administration
NCT01638364 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Nitrous Oxide: A Dose-Response Analysis - 5
NCT00000253 ·Status: COMPLETED ·Phase: NA
-
Cannabis Effects on Driving-related Skills of Young Drivers
NCT01592409 ·Status: COMPLETED ·Phase: NA
-
New Psychoactive Substances in Intoxicated Patients During the Winter Activities
NCT04155281 ·Status: COMPLETED
-
A Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects
NCT03609775 ·Status: COMPLETED ·Phase: PHASE1
-
Individual Differences in the Response to Drugs
NCT02485158 ·Status: COMPLETED ·Phase: NA
-
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252 ·Status: COMPLETED ·Phase: PHASE2
-
Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines
NCT00650130 ·Status: COMPLETED
-
Cannabis Edibles and Simulated Driving
NCT06595576 ·Status: COMPLETED ·Phase: NA
-
Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System
NCT03854942 ·Status: TERMINATED ·Phase: PHASE1
-
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
NCT00329394 ·Status: SUSPENDED ·Phase: PHASE3
-
Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT00000258 ·Status: COMPLETED ·Phase: NA
-
Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8
NCT00000256 ·Status: COMPLETED ·Phase: NA
-
Divided Drug Delivery
NCT02869724 ·Status: UNKNOWN ·Phase: NA
-
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000255 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects
NCT01710670 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
NCT05379959 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Characterization of the Prosocial and Prosexual Effects of GHB
NCT02342366 ·Status: COMPLETED ·Phase: NA
-
Physiological, Behavioral and Subjective Effects of Drugs (GHB)
NCT00058955 ·Status: COMPLETED ·Phase: PHASE1